BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22247462)

  • 1. Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma.
    Ventura LM; Feuer WJ; Porciatti V
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):659-63. PubMed ID: 22247462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.
    Saleh M; Nagaraju M; Porciatti V
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4564-72. PubMed ID: 17898279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study.
    Ventura LM; Porciatti V
    Ophthalmology; 2005 Jan; 112(1):20-7. PubMed ID: 15629815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma.
    Karaśkiewicz J; Penkala K; Mularczyk M; Lubiński W
    Doc Ophthalmol; 2017 Apr; 134(2):89-97. PubMed ID: 28176172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a novel telemetric sensor to study interactions of intraocular pressure and ganglion-cell function in glaucoma.
    Al-Nosairy KO; van den Bosch JJON; Pennisi V; Mansouri K; Thieme H; Choritz L; Hoffmann MB
    Br J Ophthalmol; 2021 May; 105(5):661-668. PubMed ID: 32727728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-up tilt lowers IOP and improves RGC dysfunction in glaucomatous DBA/2J mice.
    Porciatti V; Nagaraju M
    Exp Eye Res; 2010 Mar; 90(3):452-60. PubMed ID: 20036238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice.
    Nagaraju M; Saleh M; Porciatti V
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4573-9. PubMed ID: 17898280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern electroretinogram progression in glaucoma suspects.
    Ventura LM; Golubev I; Feuer WJ; Porciatti V
    J Glaucoma; 2013 Mar; 22(3):219-25. PubMed ID: 22071557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study.
    Tirsi A; Gliagias V; Sheha H; Patel B; Moehringer J; Tsai J; Gupta R; Obstbaum SA; Tello C
    J Curr Glaucoma Pract; 2023; 17(4):178-190. PubMed ID: 38269268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing three different modes of electroretinography in experimental glaucoma: diagnostic performance and correlation to structure.
    Wilsey L; Gowrisankaran S; Cull G; Hardin C; Burgoyne CF; Fortune B
    Doc Ophthalmol; 2017 Apr; 134(2):111-128. PubMed ID: 28243926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure lowering is associated with an increase in the photopic negative response (PhNR) amplitude in glaucoma and ocular hypertensive eyes.
    Niyadurupola N; Luu CD; Nguyen DQ; Geddes K; Tan GX; Wong CC; Tran T; Coote MA; Crowston JG
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1913-9. PubMed ID: 23385794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective ganglion cell functional loss in rats with experimental glaucoma.
    Fortune B; Bui BV; Morrison JC; Johnson EC; Dong J; Cepurna WO; Jia L; Barber S; Cioffi GA
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1854-62. PubMed ID: 15161850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-down posture induces PERG alterations in early glaucoma.
    Ventura LM; Golubev I; Lee W; Nose I; Parel JM; Feuer WJ; Porciatti V
    J Glaucoma; 2013 Mar; 22(3):255-64. PubMed ID: 22138883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern electroretinogram in glaucoma suspects: new findings from a longitudinal study.
    Bode SF; Jehle T; Bach M
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4300-6. PubMed ID: 21372021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern electroretinogram abnormality and glaucoma.
    Ventura LM; Porciatti V; Ishida K; Feuer WJ; Parrish RK
    Ophthalmology; 2005 Jan; 112(1):10-9. PubMed ID: 15629814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-down Posture in Glaucoma Suspects Induces Changes in IOP, Systemic Pressure, and PERG That Predict Future Loss of Optic Nerve Tissue.
    Porciatti V; Feuer WJ; Monsalve P; Triolo G; Vazquez L; McSoley J; Ventura LM
    J Glaucoma; 2017 May; 26(5):459-465. PubMed ID: 28263259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo.
    Sehi M; Grewal DS; Feuer WJ; Greenfield DS
    Vision Res; 2011 Jan; 51(2):235-42. PubMed ID: 20813123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern-reversal electroretinograms from normotensive, hypertensive and glaucomatous eyes.
    Wanger P; Persson HE
    Ophthalmologica; 1987; 195(4):205-8. PubMed ID: 3431818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term PERG monitoring of untreated and treated glaucoma suspects.
    Gordon PS; Kostic M; Monsalve PF; Triolo G; Golubev L; Luna G; Ventura LM; Feuer WJ; Porciatti V
    Doc Ophthalmol; 2020 Oct; 141(2):149-156. PubMed ID: 32152920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma.
    Porciatti V; Saleh M; Nagaraju M
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):745-51. PubMed ID: 17251473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.